Synedica Semaglutide Injection Kit contains semaglutide, a GLP-1 receptor agonist studied for its effects on appetite regulation, glucose control, and metabolic balance. Semaglutide is the active compound behind well-known treatments such as Ozempic, which are prescribed in clinical settings for metabolic and weight-related conditions.
This Synedica formulation is designed for controlled use in medical or research environments, where GLP-1 pathway activity is being evaluated.
Mechanism of Action
Semaglutide works by mimicking the natural GLP-1 hormone, which plays a key role in regulating:
- Appetite and satiety signalling
- Post-meal glucose response
- Insulin secretion and sensitivity
- Digestive rate and energy intake
By enhancing GLP-1 activity, it is widely studied in metabolic science for its influence on calorie intake and glycaemic control.
Kit Composition
The Synedica Semaglutide 1mg Injection Pen Kit typically includes:
- 2 prefilled injection pens
- 12 disposable sterile needles
- Instruction leaflet for handling reference
Each pen is designed to deliver measured quantities across multiple uses depending on clinical or research protocols.
Research and Clinical Context
- Metabolic efficiency
- Appetite regulation pathways
- Glucose and insulin dynamics
- Body weight management mechanisms
Storage & Handling
Store refrigerated at 2–8°C, avoid freezing, and protect from direct light. Proper handling ensures stability and consistency during use.
Synedica Semaglutide Injection Kit is a GLP-1–based formulation used in clinical and research environments to study metabolic regulation, appetite control, and glucose metabolism.
